BRIEF published on 11/12/2024 at 13:05, 1 year 9 months ago Yunu nomme Patrick McNamara pour accélérer sa croissance Yunu Développement Des Affaires Sciences De La Vie Patrick McNamara Imagerie D'essais Cliniques
BRIEF published on 11/12/2024 at 13:05, 1 year 9 months ago Yunu Appoints Patrick McNamara to Accelerate Growth Business Development Life Sciences Yunu Clinical Trial Imaging Patrick McNamara
PRESS RELEASE published on 11/12/2024 at 13:00, 1 year 9 months ago Yunu Welcomes Veteran Life Sciences Commercial Leader Patrick McNamara Yunu appoints Patrick McNamara as Senior VP of Business Development to drive growth initiatives in life sciences sector with expertise in clinical trial imaging workflow and data management solutions Business Development Life Sciences Yunu Clinical Trial Imaging Patrick McNamara
BRIEF published on 09/12/2024 at 13:05, 1 year 11 months ago Yunu étend l'utilisation gratuite de la plateforme du centre de cancérologie pour tous les essais cliniques du groupe d'oncologie pédiatrique Yunu Recherche Clinique Technologie D'imagerie Essais Cliniques Du COG Cancer Pédiatrique
BRIEF published on 09/12/2024 at 13:05, 1 year 11 months ago Yunu Extends Free Cancer Center Use of Platform for All Children's Oncology Group Clinical Trials Clinical Research Imaging Technology Yunu COG Clinical Trials Pediatric Cancer
PRESS RELEASE published on 09/12/2024 at 13:00, 1 year 11 months ago Yunu Extends Free Cancer Center Use of Platform for All Children’s Oncology Group Clinical Trials Yunu extends free platform use for Children's Oncology Group (COG) trials nationwide, providing world-class imaging capabilities and transforming pediatric cancer care Clinical Trials Yunu Imaging Workflow Pediatric Cancer Children's Oncology Group
BRIEF published on 07/23/2024 at 13:05, 2 years 1 month ago Taux d'erreur d'imagerie de 50 % dans les essais cliniques discutés par des panélistes d'experts de 5 centres de cancérologie désignés par le NCI Essais Cliniques Recherche Médicale Oncologie Erreurs D'imagerie Plateforme Yunu
BRIEF published on 07/23/2024 at 13:05, 2 years 1 month ago 50% Imaging Error Rate in Clinical Trials Discussed by Expert Panelists from 5 NCI-Designated Cancer Centers Clinical Trials Oncology Medical Research Imaging Errors Yunu Platform
PRESS RELEASE published on 07/23/2024 at 13:00, 2 years 1 month ago 50% Imaging Error Rate in Clinical Trials Discussed by Expert Panelists from 5 NCI-Designated Cancer Centers Panel at AACI-CRI symposium highlights concerning imaging accuracy crisis in clinical trials. Yunu's platform addresses issues, leading to significant workflow efficiencies Clinical Trials Yunu Imaging Accuracy Workflow Efficiencies AACI-CRI Symposium
BRIEF published on 05/08/2024 at 13:05, 2 years 4 months ago Yunu Introduces Advanced Imaging Workflow for Investigator-Initiated Trials Data Management Yunu Clinical Trial Imaging Cloud-based Platform Investigator-initiated Trials
Published on 09/11/2026 at 23:00, 1 hour 23 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 2 hours 18 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 2 hours 58 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 7 hours 23 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 7 hours 23 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 22:15, 2 hours 8 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 2 hours 13 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 4 hours 38 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 6 hours 8 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 17 hours 23 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 17 hours 23 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 17 hours 23 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 17 hours 23 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 4 hours ago Availability of the 2026 Interim Financial Report
